Short Interest in First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Increases By 53.6%

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw a significant growth in short interest in January. As of January 15th, there was short interest totaling 55,046 shares, a growth of 53.6% from the December 31st total of 35,837 shares. Based on an average trading volume of 38,396 shares, the short-interest ratio is presently 1.4 days. Currently, 0.8% of the company’s stock are sold short. Currently, 0.8% of the company’s stock are sold short. Based on an average trading volume of 38,396 shares, the short-interest ratio is presently 1.4 days.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Several institutional investors have recently bought and sold shares of FBT. High Point Wealth Management LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter worth approximately $26,000. Russell Investments Group Ltd. boosted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock worth $29,000 after purchasing an additional 158 shares during the last quarter. Rossby Financial LCC boosted its holdings in First Trust NYSE Arca Biotechnology Index Fund by 160.0% during the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock worth $31,000 after purchasing an additional 104 shares during the last quarter. Capital Investment Advisory Services LLC grew its position in First Trust NYSE Arca Biotechnology Index Fund by 63.1% in the third quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock valued at $32,000 after purchasing an additional 70 shares in the last quarter. Finally, Hazlett Burt & Watson Inc. increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 101.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 201 shares of the company’s stock valued at $36,000 after buying an additional 101 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Stock Up 0.5%

FBT traded up $1.15 during trading on Monday, hitting $214.08. The company had a trading volume of 49,653 shares, compared to its average volume of 409,879. The company has a market capitalization of $224.78 million, a PE ratio of 21.72 and a beta of 0.65. First Trust NYSE Arca Biotechnology Index Fund has a one year low of $141.38 and a one year high of $224.94. The firm’s 50-day moving average price is $212.76 and its 200 day moving average price is $191.54.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.